Peter E. Boyd, See Remarks at Aquestive Therapeutics, Inc. (AQST), sold 15,000 shares at $5.30 ($80K) on 2025-09-05, disclosed to the SEC on 2025-09-08.
Scheduled sale ($80k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AQST | SELL | 2025-09-29 | $63K | — | Filing → |
| AQST | BUY | 2022-06-15 | $4K | — | Filing → |
| AQST | BUY | 2022-06-10 | $2K | — | Filing → |